Product category:
Microplates/microarrays and readers
News Release from: Roche Nimblegen
Edited by the Laboratorytalk Editorial
Team on 17 March 2008
NimbleGen and Affymetrix expand license
agreement
Roche NimbleGen, a company of Roche Applied Science, and Affymetrix have expanded the terms of the license to a number of Affymetrix patents originally granted in October 2006
The expanded license now provides certain diagnostic rights for array-based DNA copy number analysis and array-based re-sequencing in addition to covering the manufacture, use and sale of nucleic acid microarrays and related products and services in the research field Financial details of the expanded license were not disclosed
This article was originally published on Laboratorytalk on 16 Dec 2005 at 8.00am (UK)
Related stories
Prevalence of genomic deletions between humans
Researchers at the University of Chicago and the Wellcome Trust Sanger Institute have determined that small deletions in the human genome occur in a much greater number than previously assumed
Roche NimbleGen is an innovator, manufacturer and supplier of a proprietary suite of DNA microarrays, consumables, instruments and services.
Roche NimbleGen uniquely produces high-density arrays of long oligo probes that provide greater information content and higher data quality necessary for studying the full diversity of genomic and epigenomic variation.
The improved performance is made possible by Roche NimbleGen's proprietary Maskless Array Synthesis (MAS) technology, which uses digital light processing and rapid, high-yield photochemistry to synthesise long oligo, high-density DNA microarrays with extreme flexibility.
• Roche Nimblegen: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
